Pazopanib treatment slows progression and stabilizes disease in patients with taxane-resistant cutaneous angiosarcoma
Crossref DOI link: https://doi.org/10.1007/s12032-016-0831-z
Published Online: 2016-09-09
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ogata, Dai
Yanagisawa, Hiroto
Suzuki, Kenji
Oashi, Kohei
Yamazaki, Naoya
Tsuchida, Tetsuya
License valid from 2016-09-09